MicrofluidX secures £1m funding via Innovate UK Investor Partnerships Future Economy programme, supported by Longwall Ventures. Stevenage, UK– MicrofluidX (MFX), a UK-based developer of technologies that streamline the development and deployment of cell and gene therapies, is delighted to announce that it has been awarded £685,000 in funding from Innovate UK via their Investor Partnership […]
WATERTOWN, Mass. — Fluent BioSciences, a leader in breakthrough single-cell analysis technology, and Element Biosciences, a pioneer in novel sequencing solutions, are excited to announce their collaboration to enhance the accessibility and scalability of single-cell RNA sequencing (scRNA-seq). Single-cell RNA sequencing has been a crucial tool in unraveling cellular and molecular diversity within complex tissues. […]
CellAssist Software Release 5.0 provides advanced capabilities to accurately count cells and measure their confluence using quantitative phase imaging (QPI) and proprietary algorithms BOSTON — Thrive Bioscience Inc., a provider of innovative automated live cell imaging instruments and software, debuted its CellAssist Software Release 5.0, a new integrated suite of advanced live cell imaging capabilities […]
Miltenyi Biotec to supply scalable, GMP-compliant, PRAME-targeted TCR-NK cell therapy product using the CliniMACS Prodigy® system for clinical development and future commercial supply Syena secures exclusive license to Miltenyi Biotec’s PRAME TCR Syena, co-founded by Replay and MD Anderson in 2023, will develop an off-the-shelf PRAME TCR-NK cell therapy, with IND anticipated Q1 2024 Bergisch […]
NORTH BRUNSWICK, N.J. — TheWell Bioscience, a pioneer of 3D biomimicking platforms for precision medicine, cell therapy, and biomanufacturing, announces the launch of VitroGel®-Based Cell Invasion Assay Kits. Using the xeno-free VitroGel® hydrogels, these new kits revolutionize how researchers study cell migration and invasion, offering unprecedented accuracy, efficiency, and reliability for cell migration assays. The VitroGel-Based Cell […]
Biotech company, Cytomos (www.cytomotos.com) is pleased to announce the creation of its newly named AuraCyt™ cell analysis technology brand and the launch of its enhanced website www.cytomos.com – encapsulating the transformative R&D benefits of its ground-breaking cell analysis technology. AuraCyt™ provides information on AuraCyt™ provides information on cell properties that is set to revolutionise analytical technology (PAT) […]
MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH) today announced that Lunaphore, a Bio-Techne brand, and SIB Swiss Institute of Bioinformatics, have been awarded Innosuisse funding for an innovation project. The collaboration aims to develop novel AI-based assay development tools for spatial biology on Lunaphore’s COMET™ to further accelerate the adoption of multiplex sequential immunofluorescence (seqIF™) technology in research. Spatial […]
Funding will drive expansion of company’s product portfolio and commercial reach. SEATTLE — Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has closed a total of $50 million in financing from a Series C equity raise and the closing of a debt facility. Soleus Capital led the Series […]
InSphero, the global leader in 3D in vitro technology for drug safety and efficacy testing, is proud to announce the appointment of Paul Clémençon, MBA as the new Chief Business Officer (CBO), further strengthening its Executive team. Zürich, Switzerland — InSphero, the global leader in 3D in vitro technology for drug safety and efficacy testing, is proud to announce […]
COLUMBUS, Ohio — Mettler-Toledo International Inc. (NYSE: MTD) announced today that Robert F. Spoerry will retire and not stand for re-election to the Board of Directors at the annual meeting of shareholders on May 9th, 2024. Mr. Spoerry served Mettler-Toledo for 40 years, including as the CEO from 1993 until 2007, and Chair of the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
